69.50MMarket Cap-7.10P/E (TTM)
3.870High3.740Low4.80KVolume3.740Open3.895Pre Close18.10KTurnover0.04%Turnover RatioLossP/E (Static)18.29MShares7.28052wk High3.78P/B42.66MFloat Cap2.20052wk Low--Dividend TTM11.23MShs Float13.130Historical High--Div YieldTTM3.34%Amplitude2.200Historical Low3.769Avg Price1Lot Size
Genenta Science Stock Forum
Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing
Thursday, 9th January at 6:00 am
MILAN and NEW YORK, Jan. 09, 2025 (GLOBE NEWSWIRE) -- Genenta Science (NASDAQ: GNTA), a pioneer in immuno-oncology and a leader in cell-based therapeutics, is pleased to announce that it has strengthened its partnership with AGC Biologics, a global contract development and manufacturing organization (CDMO), by amending their Development and Master S...
Genenta Secures Approval for Innovative Trial for Metastatic Renal Cell Cancer
Genenta Science (NASDAQ: GNTA) has received approval from AIFA for a new Phase 1 clinical trial for metastatic Renal Cell Cancer (mRCC), expanding potential applications for its flagship product, Temferon™. This approval aligns with EMA standards. The company's ongoing TEM-GBM development program has completed a Phase 1 dose-ranging trial, confirming no dose-limiting toxicities across ...
it looks like this dip is an error. im not seeing the dip on my TD Ameritrade platform.
jumping in here..
No comment yet